leflunomide has been researched along with Glomerulonephritis, Minimal Change in 2 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
| Excerpt | Relevance | Reference |
|---|---|---|
| " During the treatment, 8 patients had adverse effects which could be well tolerated." | 1.39 | Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease. ( Huang, J; Li, J; Liu, G; Xu, R; Zhang, Y; Zhou, J, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, C | 1 |
| Cui, Z | 1 |
| Zhang, Y | 2 |
| Wang, F | 1 |
| Wang, X | 1 |
| Cheng, X | 1 |
| Meng, L | 1 |
| Liu, G | 2 |
| Zhao, M | 1 |
| Zhou, J | 1 |
| Li, J | 1 |
| Xu, R | 1 |
| Huang, J | 1 |
2 other studies available for leflunomide and Glomerulonephritis, Minimal Change
| Article | Year |
|---|---|
Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis.
Topics: Adult; Cyclosporine; Glomerulosclerosis, Focal Segmental; Humans; Leflunomide; Nephrosis, Lipoid; Ne | 2022 |
Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease.
Topics: Adolescent; Adult; Drug Resistance; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomid | 2013 |